Survival Outcome in True Carcinoma of Unknown Primary (tCUP) with p16 + Cervical Metastasis

• Published in: International Archives of Otorhinolaryngology 2023-10, Vol.27 (4), p.e687-e693
• Main Authors: Faisal, Muhammad, Le, Nguyen-Son, Grasl, Stefan, Pammer, Johannes, Janik, Stefan, Heiduschka, Gregor, Schratter-Sehn, Annemarie U., Franz, Peter, Königswieser, Meinhard, Grasl, Matthaeus Ch, Erovic, Boban M.
• Format: Article
• Language: English
• Subjects: head and neck neoplasms; neoplasm metastasis; Original Research; OTORHINOLARYNGOLOGY; unknown primary
• ISSN: 1809-9777; 1809-4864; 1809-4864
• DOI: 10.1055/s-0042-1759575

Introduction Age and lymph node ratio have been attributed as independent predictors for survival and recurrence in carcinoma of unknown primary (CUP). Objective The purpose of this study was to analyze the prognostic value of p16 overexpression for CUP in the absence of true primary (TP). Methods The study involved 43 patients who underwent therapeutic lymph node dissection (LND) from 2000 to 2015 after all the diagnostic work up for CUP. Immunohistochemistry for p16 overexpression was performed. Cox proportional hazard regression analysis was used to analyze the prognostic impact on 5-year overall survival (OS) and recurrence-free survival (RFS). Results The male-to-female ratio was 5.1:1, with a median age of 62 years. The clinicopathological data, except for p16 overexpression, did not differ significantly in terms of 5-year OS and RFS. The Cox regression analysis proposed p16 positivity to be an independent prognosticator of regional recurrence-free survival (RRFS) (hazard ratio [HR] 6.180, p = 0.21). The median time to recurrence and death were 10 and 25 months, respectively. Conclusion Cervical metastasis with p16 overexpression is a significant prognostic factor of improved RFS after surgery in CUP. The prognostic significance of lymph node p16 positivity should be further studied.